Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ZY

Zymergen (ZY) Stock Price, News & Analysis

Zymergen logo

About Zymergen Stock (NASDAQ:ZY)

Advanced Chart

Key Stats

Today's Range
$2.43
$2.43
50-Day Range
$2.35
$3.14
52-Week Range
$1.10
$12.42
Volume
85 shs
Average Volume
1.23 million shs
Market Capitalization
$253.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.

Receive ZY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zymergen and its competitors with MarketBeat's FREE daily newsletter.

ZY Stock News Headlines

“You all just got a lot richer”
Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crashes. Do you think that’s an accident? When he threatens to “End the Fed” do you think he doesn’t know banking stocks will benefit? What about when he tells his followers, “Now is a good time to buy,” hours before relaxing tariffs and sending the market soaring? Is that an accident? Larry Benedict doesn’t think so. He thinks Trump knows what he’s doing… and believes he’s found the perfect tickers for everyday Americans to take advantage next time he triggers a big move.
Ginkgo Bioworks: Broken Narrative
See More Headlines

ZY Stock Analysis - Frequently Asked Questions

Zymergen (ZY) raised $401 million in an IPO on Thursday, April 22nd 2021. The company issued 13,600,000 shares at $28.00-$31.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen, UBS Investment Bank and Lazard acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zymergen investors own include Tesla (TSLA), NIO (NIO), Meta Platforms (META), PayPal (PYPL), Snowflake (SNOW) and Teladoc Health (TDOC).

Company Calendar

Today
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:ZY
Fax
N/A
Employees
502
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$361.79 million
Net Margins
-2,508.94%
Pretax Margin
-2,508.42%

Debt

Sales & Book Value

Annual Sales
$16.74 million
Price / Cash Flow
N/A
Book Value
$3.99 per share
Price / Book
0.61

Miscellaneous

Free Float
92,145,000
Market Cap
$253.58 million
Optionable
Not Optionable
Beta
1.69

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:ZY) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners